New advice to GPs from the Australian and New Zealand College of Anaesthetists (ANZCA) on prescribing medicinal cannabis puts patients at risk and could drive them further towards the black market, according to industry leaders.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

The industry has reacted with dismay to the advice not to prescribe medicinal cannabis products to treat chronic non-cancer pain (CNCP) unless they are part of a registered clinical trial.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...